Denosumab in Bisphosphonate-Refractory Polyostotic Fibrous Dysplasia in McCune–Albright Syndrome: A Case Report
International Journal of Drug Delivery Technology · 11.06.2026 · 16 (52s)
DOI: 10.25258/ijddt.16.52s.95 ↗Kurz gefasst
Fallbericht in der Zeitschrift International Journal of Drug Delivery Technology, online erschienen am 11.06.2026. Verfasst von Kavya Paturi und 4 weiteren Autor:innen.
Abstract (Originalsprache)
McCune–Albright syndrome (MAS) is a rare mosaic disorder characterized by polyostotic fibrous dysplasia (PFD), café-aulait macules, and hyperfunctioning endocrinopathies. Management of skeletal disease remains challenging, particularly in patients with incomplete response to bisphosphonates. We report a 15-year-old male with clinically diagnosed MAS presenting with extensive PFD, craniofacial involvement with optic nerve compression, multiple low-trauma fractures due to bone involvement, and markedly elevated alkaline phosphatase (ALP). Despite two years of intravenous zoledronate therapy, biochemical response was partial, with persistently elevated ALP levels. Following transition to Denosumab, ALP declined from 1284 U/L to 294 U/L within one treatment cycle. Subsequent values showed fluctuation but remained overall lower than pre-denosumab levels. Clinically, the patient reported reduction in bone pain and no new fractures during follow-up. This case highlights denosumab as a potential therapeutic option in bisphosphonate-refractory MAS associated PFD. However, variability in biochemical response and limited long-term safety data warrant cautious use and close monitoring.
Zitieren
APA
Paturi, K., Venkateswarlu, D., Ranjan, A., Madala, M., & Mahadevan, S. (2026). Denosumab in Bisphosphonate-Refractory Polyostotic Fibrous Dysplasia in McCune–Albright Syndrome: A Case Report. International Journal of Drug Delivery Technology, 16(52s). https://doi.org/10.25258/ijddt.16.52s.95
Vancouver
Paturi K, Venkateswarlu D, Ranjan A, Madala M, Mahadevan S. Denosumab in Bisphosphonate-Refractory Polyostotic Fibrous Dysplasia in McCune–Albright Syndrome: A Case Report. International Journal of Drug Delivery Technology. 2026;16(52s). doi:10.25258/ijddt.16.52s.95
BibTeX
@article{Paturi2026,
author = {Paturi, Kavya and Venkateswarlu, Damacharlla and Ranjan, Asha and Madala, Meghana and Mahadevan, Shriraam},
title = {Denosumab in Bisphosphonate-Refractory Polyostotic Fibrous Dysplasia in McCune–Albright Syndrome: A Case Report},
journal = {International Journal of Drug Delivery Technology},
year = {2026},
volume = {16},
number = {52s},
doi = {10.25258/ijddt.16.52s.95}
}
EUVIMED